Partner News | Published: Tuesday, November 10, 2026
Studycast, a provider of cloud-based medical imaging and reporting solutions designed to help cardiovascular practices streamline workflows, improve operational efficiency, and enhance patient care.
Partner News | Published: Tuesday, October 27, 2026
W. L. Gore & Associates, a developer of cardiac, vascular and surgical medical technologies designed to reduce complications, streamline procedures, and support long-term durability.
Partner News | Published: Monday, October 19, 2026
Penumbra, Inc., a developer of technologies that address challenging medical conditions, including venous thromboembolism (VTE), pulmonary embolism (PE), acute myocardial infarction (AMI), acute limb ischemia and ischemic stroke.
Partner News | Published: Friday, October 9, 2026
AISAP, a health-technology company bringing AI-powered cardiac diagnostics to the point of care.
Partner News | Published: Wednesday, September 30, 2026
ACIST Medical Systems, an interventional and diagnostic technology company focused on advancing cardiovascular imaging and procedural technologies.
Partner News | Published: Thursday, September 24, 2026
FillPoint Health LLC (“FillPoint Health”), a management services organization (“MSO”) with specialty pharmacy capabilities designed to help cardiovascular practices improve patient access to specialty therapies while reducing administrative burden.
Partner News | Published: Monday, September 21, 2026
Meriplex, a provider of managed information technology (IT), cybersecurity and artificial intelligence (AI) services for healthcare organizations.
Partner News | Published: Thursday, September 17, 2026
The Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model is a 10-year national test launched by the Centers for Medicare & Medicaid Services (CMS) Innovation Center.
Partner News | Published: Wednesday, September 16, 2026
Markovski brings extensive experience building and scaling regulated healthcare software platforms.
Partner News | Published: Monday, August 24, 2026
Milestone Pharmaceuticals, an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines for people living with heart rhythm disorders.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.